Prof. Frank Tacke discusses a paper in press in the Journal of Hepatology regarding the role of PPAR’s in experimental models and how these PPAR’s affect the progression of liver disease.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In